Table 1.
n | % | ||
---|---|---|---|
Totala | 66 | 100 | |
NRP1 positivea | 7 | 11 | |
NRP1 negativea | 58 | 89 | |
NRP2 positive | 7 | 11 | |
NRP2 negative | 59 | 89 | |
Gender | female | 23 | 35 |
male | 43 | 65 | |
Age (years) | < 10 | 11 | 17 |
10-24 | 39 | 59 | |
> 24 | 16 | 24 | |
Tumor type | Osteoblastic | 45 | 68 |
Chondroblastic | 11 | 17 | |
Fibroblastic | 6 | 9 | |
Telangiectatic | 4 | 6 | |
Anatomical Site | Tibia/fibula/calcaneus | 21 | 32 |
Femur | 24 | 36 | |
Humerus/ulna | 6 | 9 | |
Jaws/facies/vertebrae column/pelvis | 15 | 23 | |
Chemotherapy response | Responders | 29 | 44 |
Non-responders | 23 | 35 | |
No neoadjuvant chemotherapy | 12 | 18 | |
Missing information | 2 | 3 | |
Metastasis | No metastasis | 43 | 65 |
Total metastasis | 23 | 35 | |
Metastasis at diagnosis | 5 | 8 | |
Metastasis after diagnosis | 18 | 27 |
The total number of patients evaluated for NRP1 staining = 65.